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Differences in activity among the family of human IFNs a are much reduced if these ligands are assayed on bovine ceils. In particular, the activity 
of IFN ctD is much higher on bovine than on human cells. To examine these differences, the bovine counterpart of the human IFNAR has been 
cloned and expressed in a human cell line. The transfected cell line now recognizes the human IFN '~D az a high-slXeilic-activity IFN ~ubtyl~, 
indicating that the differences in sensitivity between the bovine and human cells to the human IFN ~ lie in the structure of the IFNAR chain rather 
than in the ether cemponents of lhe functional receptor. 
l,lterferon; Interferon receptor; Bovine; Transfection; Cytokine receptor family 
1. INTRODUCTION 
Apart from their antiviral activities, by which they 
were first described, the interferons (IFNs) show nega- 
tive effects on the proliferation of cultured cells and 
possess basic immuno-modulatory effects at the level of 
B-cell, T.cell and macrophage activation [1]. By itself 
the human type 1 IFN family consists of 15-20 species 
of 1FN ct and IFN ,8 encoded by as many structural 
genes. The reasons for the evolutionary selection of 
such a gene family encoding type 1 IFNs are largely 
unknown but there seems to have been pressure to re- 
tain more than one type I IFN gene in mammals [2,3]. 
An examination of the familial differences i therefore 
important in assessing the functional significance of this 
multiplicity of related ligands. 
On human cells, all the IFN o~ and fl species compete 
fr the same receptor system on the cell surface [4,5] but 
the individual subtypes how different specific antiviral 
or antiproliferative activities [6-8]. It has been shown 
that the quantitative differences between the IFN sub- 
types are related to their binding behaviors at the cell 
surface [9]. In particular, IFN otD shows a mttch lower 
binding affinity for human membrane receptors than 
either IF1N aA or 0cB [10]. However, on bovine cells, 
human ~ IFNs exhibit a pronounced cross-reaction a d 
all subtypes, including czD, have the same high 
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specific activities and behave similarly at the receptor 
level [6- 8,11-13]. It is thus reasonable to assume that, 
compared to the human receptor, the bovine functional 
receptor unit exhibits critical differences which allow it 
to bind all human o~ IFN subtypes with the same high 
affinity. 
One component of both the human and the mouse 
type I IFl'q functional receptor unit has been already 
characterized [14,15]. This transmembrane protein, 
called IFNAR for IFN ~z receptor, isstructurally related 
to other members of the cytokine receptor superfamily 
characterized bya 200 amino acids domain (D200) sub- 
divided in two 100 amino acids subdomains (SD100A 
and B) [16-18]. The predicted folding of each SDI00 is 
the 7 p strands (S1-$7) of the immunoglobulin constant 
domain [16,17]. When expressed in heterospecific cells, 
IFNAR participates in the functional receptor unit for 
a limited number of type I IFNs but is likely implicated 
in the mediation of the binding and activities of all type 
! IFNs when expressed in a homospeeific background 
[15,19]. The receptor system that is emerging isthus not 
simple, the results strongly suggest hat an additional 
membrane component must come into a proper steric 
contact with IFNAR for a high-affinity site to be estab- 
lished. 
In order to examine the role of the IFNAR chain in 
the peculiar behavior of the bovine receptor for human 
1FN 0t subspecies, we have cloned and sequenced the 
bovine counterpart of the human 1FNAR from MDBK 
cells. We show that, when expressed in human ceils, the 
bovine receptor is capable of high-affinity binding and 
high specific antivira! activity for all human 1FN a sub- 
species tested, including the human IFN 0tD. 
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2, MATERIALS AND METHODS 
2.1. Nucleic acids clotlhtg atul analysis methods 
Standard procedures were as described [20]. An oligo(dT)-cDNA 
library was constructed in the 3. ZAP II phage vector (Stratagene) 
from poly A ÷ RNA of MDBK cells using the eDNA synthesis system 
fl'om Amersham. Low-stringency h bridization conditions were ac- 
cording to Howley et al. [2 I] as previously described [15l. High-strin- 
gency hybridization conditions with the probe indicated in the text 
were according to Church and Gilbert [22]. All DNA fragments were 
cloned into Bluescript KS II + from Stratagene or into the mammalian 
expression vector pVADN 1 [15]. DNA sequencing and handling were 
as described [18]. 
2,2. IFNs 
Human IFNs gB (=8) and ¢D (~t) were a gift fi'om Ciba-Geigy Ltd. 
Human IFN gA {~2c) was from Bender+Co GmbH, Wien, The prep- 
aration of IFNs labeled with ~'Sl was as de.~cribed [23], Antiviral titers 
were estimated by a eytopathi¢ inhibition assay u~ing vesicular sto- 
matitis virus or ¢ncephalomyocarditis virus as challenge virus [24]. 
2.3. Cell lhws attd transfections 
Madin-Darby bovine kidney (MDBK, ATCC 6071) and human 
epithelial HEp 2 cell lines (ATCC CCL 23) were grown in Dulbeeco 
modified Eagle's medium supplemented with 10% fetal celfseruna. Tire 
HEp 2 cell line was transfectcd bythe calcium phosphate precipitation 
t~hnique [25]. Stable transfected clones were selected inthe presence 
of G418 (Gibeo) at 1 nag/ml, 
2.4. Bhtdilag e.vperhnent.~ 
Experhneatal procedures for binding experiments with iodinated 
IFNs were described in a previous article [14]. Briefly, the)' were 
carried out at 37°C on 1.10 ~ cells/well plated on six-well plates. Back- 
ground counts of non-specific binding were estimated by incubating 
controls with a 100-fold molar excess of the appropriate unlabeled 
IFN. 
3. RESULTS AND DISCUSSION 
3.1. Clonhzg of [FNAR cDNA from MDBK cells 
Oligo (dT) primed cDNAs synthetised fl'om poly(A) + 
RNA of MDBK cells were cloned in the lambda Zap 
ii phage vector. 5.6. 106 independent clones of this li- 
brary were screened with two probes derived from the 
human 1FNAR eDNA [14], One probe encodes the first 
200 amino acids of the mature extracellular part, the 
other encodes the 100 amino acids that constitute the 
intraeytoplasmie domain of the human receptor. Low 
stringency hybridization conditions used according to 
Howley et al. [21] resulted in the identification of two 
phage clones: MD1 andMD5, Restriction map and se- 
quence analysis revealed that they contained overlap- 
ping cDI'4A insertz recognized by the human probes. 
These ¢DNAs are schematically depicted in Fig. I A. 
Their sequences have been deposited in the EMBL data 
library (accession No, X68443) and are available upon 
request. The MD5 sequence consists of 2,645 bp plus a 
28-residue stretch of  adenine 21 bp downstream of a 
polyadenylation signal AATTAAA, and contains an 
open reading frame of i,680 bp starting at nucleotide 
125 and closed at both 5' and 3' ends by termination 
codons. When hybridized on RNA from MDBK cells 
on Northern blot, the 5" Hind IIl fragment of the eDNA 
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Fig, 1. A: schematic diagram representing the various overlappin8 
eDN %; B: Northern blot anal~,sis of 10 #g of RNA from bovine 
MDBK cells hybridized with MD5 (lane 1) or the 3' sequence ofMDd 
(lane 2). 
MD5 (nucleotide 1 to 607) detects three transcripts of 
6 kb0 4 kb and 2.7 kb (Fig. 1B, lane 1). The same result 
was obtained using a probe corresponding to the 3' end 
of the MD5 eDNA (data not shown). We thus consid- 
ered the possibility that the length discrepancy between 
the eDNA MD5 (2,7 kbp) and the mRNAs of 6 and 4 
Kb was due to incomplete 5' or 3' regions. The existence 
of an additional sequence in the 5' region of MD5 
eDNA was tested by the polymerase chain reaction with 
single-sided specificity as described [15], but we were 
unable to show the presence of such a seqttence, even 
if RNA from MDBK cells was denatured with methyl 
mercury prior to the reverse transcription. However, a 
search for 3' sequences of  MD5 eDNA was successful: 
the MDBK eDNA library was resereened with a Stu- 
I-MluI restriction fragment of the MD5 eDNA (nucleo- 
tide 2025 to 2560). A new clone (MDd) with a 1,1 kbp 
insert overlapping with MD5 was isolated; it is schemat- 
ically depicted in Fig. IA. Its 5' extremity corresponds 
[O ll'UCll~Otltd~ 2), / I On  I.ll~ scq~,~t~C KIA /.¥,L l .~  ~ I~k I It I1~ lh , l k~&l"  
tical to MD5 up to nucleotide 2645,just upstream of the 
poly A stretch of MD5. At this position, MDd contains 
an additional non coding 585 bp sequence (EMBL ac- 
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Fig. 2. Predictive alignment of protein sequences orthe bovine (b), human (h) and murine (m) IFNAR. Tile amino acids are represented according 
to the one letter code. Leader peptides (L) and transmembrane regions (TM) are stressed by large heavy boxes. Small heavy boxes with the dipeptJde 
'PP' correspond to the hinge regions between S D 100A and SD 100B and betw~n SD100A" and SD 100 B'. The trip, pride small heavy box corresponds 
to the hinge region between the two D200. Predicted,8 strands are boxed and numbeled S1-$7. SDi00A corresponds approximately to positions 
30-i 30, SD 100B corresponds approximately to positions 130-230, SD 100A" corresponds approximately to position s 230-335, SD 100B' co rresponds 
approximately to positions 335-430. Stars indicate positions that are conserved inthe three sequences. Lines indicate positions that are conserved 
only between haman and bovine sequences. Dots indicate the positions that are conserved between the routine and only one of the other two 
sequences. 
cession no. X68443). In order to demonstrate that the 
length discrepancy between the three transcripts de- 
tected with MD5 is due to the presence of  sequences in 
the 3' region to the shorter 2.7 kb transcript, we hybrid- 
ized the 3' sequence of MDd (nucleotide 2792 to 3194) 
on RNA from MDBK ceils (Fig. I B) lane 2). indeed, 
this probe detects only the two longer transcripts of 6 
and 4 kb but not the 2.7 kb mRNA.  The three tran- 
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scripts detected with MD5 can thus be explained by 
alternative use of polyadenylation sites which generate 
different lengths of the 3' untranslated regions. 
This result strongly suggests that the eDNA MD5 
corresponds to the 2.7 kb mRNA and that it contains 
the complete open reading frame encoding the bovine 
IFNAR. Despite the lowest abundance of the 2.7 kb 
transcript, he first screening of the eDNA library with 
human probes did not allow us to isolate the two longer 
cDNAs, Because of the efficiency of reverse transcrip- 
tion and the location of the probes, it is likely that 
cDNAs originating from the shortest ranscript were 
selectively cloned. 
3.2. Structural comparison of the boy#w, human and 
murine IFNARs 
The open reading frame of the eDNA MD5 encodes 
a 560 amino acid protein showing the typical structure 
of an interferon receptor, including a 24 amino terminal 
hydrophobic stretch canonical for a signal peptide [26]. 
Another stretch of 25 hydrophobic residues bisect the 
polypeptide into a putative extracellular part of 413 
amino acids and a putative intracytoplasmic region of 
98 amino acids. 15 characteristic motifs of N-linked 
glycosylation are found, including 2 in the intracellular 
domain. 
Fig. 2 presents an alignment between the bovine and 
the two other known IFNAR sequences [14,15]. This 
alignment has been obtained by the clustal program [27] 
and refined by hydrophobic cluster analysis [28] to en- 
sure the conservation i  the bovine and mouse IFNARs 
of the fl strands predicted by Bazan [16] and Thoreau 
et al. [17] for the human IFNAR and confirmed recently 
by the determination f the structure of anot, her mem- 
ber of the growth hormone/prolaetin/cytokine rec ptor 
family [29]. Gaps have been found in the predicted loops 
rather than in the predicted fl strands. It is apparent 
from this alignment, hat the predicted folding of the 
human IFNAR is conserved for the bovine and murine 
receptors with four immunoglobulin-like constant-do- 
main structural units (SD100A, B, A' and B'). All cyste- 
ine positions are conserved between the human and the 
bovine receptor except Cys ~-~ which appears to be iso- 
lated in the $7 fl strand of SD100B of the bovine 
IFNAR. Three potential N-linked glycosylation sites 
are conserved in the three receptors. It is interesting to 
note that both $6--$7 loops of the two SD100A contain 
a conserved glycosylation sequence and that the third 
conserved putative site is in the predicted $3-$4 loop of 
SD100B'. The intracytoplasmic domain of the bovine 
1FNAR has the same length as the human, rather titan 
the longer intracytoplasmie domain exhibited by the 
mouse IFNAR. The most obvious point in the align- 
ment of :his domain is the stretch of !6 a,nino acids 
perfectly conserved in the three species which could be 
implicated in interaction with in tracytoplasmie compo- 
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Fig. 3. A: binding activity of parental human HEp 2 cells (open 
symbols) or human HEp 2 cells transfected with the bovine IFNAP, 
(closed symbols) Ibr the human IFN gA (circles). ~xB (triangles) and 
~D (squares)', B:specific antiviral activity of ha,nan IFNs aA. gB and 
~zD assayed on bovine MDBK cells (black column), parental human 
HEp 2 ceils (striped column) or human HEp2 cells transfected with 
the bovine IFNAR (dotted column). 
3.3. Expression oJ" the bovine IFNAR in human cells 
The open reading frame containing the 5' Pvu II frag- 
ment of MD5 eDNA (nucleotides 1 to 2150) was cloned 
downstream of the adenovirus 2 major late promoter in 
the mammalian expression vector pVADN1 to obtain 
pVADNIMD56. This plasmid was transfected into the 
human HEp 2 ceil line and stable transfeetants were 
selected in the presence of G418. One transfectant 
named HBB64 was selected on the basis of tile expres- 
sion of the bovine IFNAR mRNA and was further 
analysed. 
Fig. 3A shows the IFN binding of various human 
IFN subtypes on proliferating parental HEp 2 cells 
(open syrnboB) and on the transfected HBB64 clone 
(closed symbols) after 1 h of contact between IFNs and 
cells, a time corresponding to a maximum uptake for 
the IFN concentration range studied. The binding was 
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measured at 37°C because it has been shown that under 
these conditions, cellular activities due to IFNs map in 
a one-to-one fashion to the activities of  the IFN-recep- 
tor complex [9,24,30]. The curves indicate that the bo- 
vine IFNAR provides high-affinity binding sites for the 
human IFN =D on the HBB64 clone whereas parental 
HEp2 cells bind this IFN with lower affinity as already 
described for the human Daudi  cell line [9]. The level of  
IFN uptake attained by IFNs ~A and o~B on the human 
cell line is now attained by IFN ~D on human ceils 
expressing bovine IFNAR.  Correlating with the uptake, 
the specific antiviral activity of  IFN ~xD on human cells 
expressing the bovine IFNAR,  approaches the activity 
measured on bovine MDBK cells in contrast to the 
specific activity o f  cxD on human parental cells which is 
100-fold lower. It is also remarkable that the uptake of  
IFNs o~A and ~xB is 0.5-1 log higher on cells expressing 
botl~ human and bovine receptors than on the parental 
haman cells. As shown in Fig. 3B, this higher binding 
activity o f  the HBB64 clone does not confer a higher 
biological activity for I FN  0:A and cxB suggesting that 
the transducing machinery can be saturated. 
These results show that the bovine counterpart  of the 
human IFNAR participates, when expressed into 
human cells, in a functional receptor unit capable o f  
recognizing the human IFN cxD as a high specific activ- 
ity I FN  cx subtype. It is thus likely that the molecular 
determinants o f  the differences in the specific activities 
of the human interferon = subtypes on human cells lie 
in the sequence of 'the IFNAR chain. 
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